Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children-Reference-Cited by-同舟云学术

Polymorphisms indicating risk of inflammatory bowel disease or antigenicity to anti-TNF drugs as biomarkers of response in children

Published:2023-08 Issue: Volume:194 Page:106859
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Zapata-Cobo Paula,Salvador-Martín Sara,Velasco Marta,Palomino Laura M.,Clemente Susana,Segarra Oscar,Moreno-Álvarez Ana,Fernández-Lorenzo Ana,Pérez-Moneo Begoña,Montraveta Montserrat,Sánchez Cesar,Tolín Mar,Loverdos Inés,Fobelo María Jesús,Navas-López Victor Manuel,Magallares Lorena,García-Romero Ruth,Sánchez-Hernández José Germán,Rodríguez Alejandro,Bossacoma Ferrán,Balboa María Jesús,Salcedo Enrique,Sanjurjo-Sáez María,López-Fernández Luis A.

Publisher

Elsevier BV

Subject

Pharmacology

Reference34 articles.

1. Pediatric inflammatory bowel disease;Bouhuys;Pediatrics,2023

2. Genes vs environment in inflammatory bowel disease: an update;Dipasquale;Expert Rev. Clin. Immunol.,2022

3. Current status and future prospects of inflammatory bowel disease genetics;Kakuta;Digestion,2023

4. Long-term outcomes with adalimumab therapy in pediatric crohn disease: associations with adalimumab exposure;Rinawi;J. Pediatr. Gastroenterol. Nutr.,2022

5. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe Crohn’s disease: an open-label multicentre randomised controlled trial;Jongsma;Gut,2022

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities;Diagnostics;2024-07-16

2. Precision Medicine in Inflammatory Bowel Disease: A Spotlight on Emerging Molecular Biomarkers;Biomedicines;2024-07-08

3. A review on current advancement in zebrafish models to study chronic inflammatory diseases and their therapeutic targets;Heliyon;2024-06

4. Understanding patient variability to biologic treatments in inflammatory bowel disease;Expert Opinion on Biological Therapy;2024-05-03

5. Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review;International Journal of Molecular Sciences;2024-03-27